Publications

Publications

A selection of recent publications (updated August 18, 2012):

  1. Chai W and Liu Z. p38 Mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kB degradation in human coronary artery endothelial cells. Endocrinology 2007, 148 (4):1622-1628. [PMID: 17234706]
  2. Li G, Barrett EJ, Barrett MO, Cao W and Liu Z. Tumor necrosis factor-α induces insulin resistance in bovine aortic endothelial cells via a p38 MAPK-dependent pathway. Endocrinology 2007, 148(7):3356-3363. [PMID: 17446186]
  3. Liu Z. Insulin at physiological concentrations increases microvascular perfusion in human myocardium. Am J Physiol Endocrinol Metab 2007, 293(11):E1233-E1241. [PMID: 17698984]
  4. Chai W, Wu Y, Li G, Cao W, Yang Z, and Liu Z. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2008, 294(1):E183-E189. [PMID: 18003719]
  5. Wang H, Wang AX, Liu Z, and Barrett EJ. Insulin signaling stimulates insulin transport by bovine aortic endothelial cells. Diabetes 2008; 57(3):540-7. [PMID: 17977956]
  6. Li G, Del Rincon J-P, Jahn LA, Wu Y, Gaylinn B, Thorner MO, and Liu Z. Growth hormone exerts acute vascular effect independent of systemic or muscle insulin-like growth factor I in humans. JCEM 2008; 93(4):1379-85. [PMCID: PMC2291494]
  7. Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, and Liu Z. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia. 2009; 52(5):752-64. [PMCID: PMC2704146]
  8. Li G, Barrett EJ, Ko S-H, Cao W, and Liu Z. Insulin and IGF-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells. Endocrinology, 2009; 150:3475-82. [PMCID: PMC2717867]
  9. Liu Z, Liu J, Jahn LA, Fowler DE, and Barrett EJ. Infusing lipid raises plasma free fatty acids and causes insulin resistance in muscle microvasculature. JCEM 2009; 94(9):3543-9.(PMCID: PMC2741712)
  10. Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, and Liu Z. Angiotensin AT1 and AT2 receptors regulate basal skeletal muscle microvascular perfusion and glucose use. Hypertension 2010; 55(2):523-30 [PMCID: PMC2818814]
  11. Chai W, Liu J, Jahn LA, Fowler DE, Barrett EJ, and Liu Z. Salsalate attenuates free fatty acids-induced microvascular and metabolic insulin resistance in humans. Diabetes Care 2011, 34(7):1634-8[PMCID: PMC3120177].
  12. Barrett EJ, Wang H, Upchurch CT, and Liu Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab 2011, 301(2):E252-E263[PMCID: PMC3154531]
  13. Chai W, Wang W, Dong Z, Cao W, and Liu Z. Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 2011, 60(11):2939-46. [PMCID: PMC3198098]
  14. Chai W, Dong Z, Wang N, Wang W, Tao L, Cao W, and Liu Z. Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism. Diabetes 2012, 61(4):888-896.
  15. Sauder MA, Liu J, Jahn LA, Fowler DE, Chai W, and Liu Z. Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans. J Clin Endocrinol Metab. 2012, 97(7):E1208-1212. [PMID: 22508711]

 

Dr. Liu's PubMed Listing